The post-Roe potential of mifepristone and misoprostol in the United States.

IF 3.4 3区医学 Q1 FAMILY STUDIES

BMJ Sexual & Reproductive Health Pub Date : 2024-10-29 DOI:10.1136/bmjsrh-2024-202603

Dana M Johnson

引用次数: 0

查看原文本刊更多论文

米非司酮和米索前列醇在美国 "Roe "事件后的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMJ Sexual & Reproductive Health Medicine-Reproductive Medicine

CiteScore

5.10

自引率

6.10%

发文量

期刊介绍： BMJ Sexual & Reproductive Health is a multiprofessional journal that promotes sexual and reproductive health and wellbeing, and best contraceptive practice, worldwide. It publishes research, debate and comment to inform policy and practice, and recognises the importance of professional-patient partnership.